Aytu BioPharma, Inc.

3mon ago, source: CNN

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments.

Aytu BioPharma, Inc. Common Stock (AYTU)

7mon ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Aytu BioPharma Inc. (AY20.SG) stock forecast and price target

11mon ago, source: Yahoo Finance

Find the latest Aytu BioPharma Inc. AY20.SG analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

A Preview Of Aytu BioPharma's Earnings

11mon ago, source: Hosted on MSN

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Thursday, 2023-05-11. Here's what investors need to know before the announcement.

Aytu BioPharma, Inc. (AY20.SG)

1mon ago, source: Yahoo Finance

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma ...

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

7h ago, source:

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that ...

Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...

15d ago, source: Yahoo Finance

Collaboration Revenue: Q4 2023: $1.8 million; Full Year 2023: $5.5 million. Research and Development Expenses: Q4 2023: $10.9 million; Full Year 2023: $40.8 million. General and Administrative ...

KPRX Kiora Pharmaceuticals, Inc.

1mon ago, source: Seeking Alpha

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead ...

Aytu BioPharma Inc

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aytu BioPharma Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aytu BioPharma Inc 0A8M

3mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...